Related references
Note: Only part of the references are listed.Dalbavancin as a second-line treatment in methicillin-resistant Staphylococcus aureus prosthetic vascular graft infection
Arturo Ciccullo et al.
INFECTION (2020)
Successful treatment of methicillin-sensitive Staphylococcus aureus tricuspid-valve endocarditis with dalbavancin as an outpatient in a person who injects drugs: A case report
Aaron Hakim et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis
Kasper Iversen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Multicenter clinical experience of real life Dalbavancin use in gram-positive infections
S. Wunsch et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)
Real-world experience with dalbavancin therapy in gram-positive skin and soft tissue infection, bone and joint infection
Selma Tobudic et al.
INFECTION (2019)
Left Ventricular Assist Device Infections and the Potential Role for Dalbavancin: A Case Report
Jessica Howard-Anderson et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
Serum Bactericidal Activity Levels Monitor to Guide Intravenous Dalbavancin Chronic Suppressive Therapy of Inoperable Staphylococcal Prosthetic Valve Endocarditis: A Case Report
Martina Spaziante et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci
Carmen Hidalgo-Tenorio et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2019)
Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of Vienna
Selma Tobudic et al.
CLINICAL INFECTIOUS DISEASES (2018)
Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE)
D. Knafl et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)
Linezolid Induced Adverse Drug Reactions - An Update
Kamal Kishor et al.
CURRENT DRUG METABOLISM (2015)
Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections
Lesley J. Scott
DRUGS (2015)
Share Paper
